Ajay Upadhyaya added over 0.9% of Sanjivani Paranteral in the quarter and now holds 1.9%, or 2,34,000 shares.
A research-based pharmaceutical company engaged in the development and manufacturing of parenteral formulations and injectable medicines. Established in 1994, the company serves both domestic and international markets across multiple therapeutic areas including oncology, cardiology, infectious diseases, and critical care. Its export-oriented business model distinguishes it as a significant player in the global pharmaceutical supply chain, maintaining compliance with stringent international regulatory and quality standards.
Co-founded Edubrite Systems, a SaaS learning platform that LinkedIn acquired in 2022, then redeployed the proceeds into Indian equities. BITS Pilani and Jamnalal Bajaj alumnus. Grew his disclosed portfolio from ₹45 Cr (2015) to ₹850+ Cr (2025), heavily concentrated in capital goods, infrastructure, and electricals: Kirloskar Electric, DCX Systems. He spotted India's infrastructure capex cycle early and bet big. A founder who knows how to compound.
